Kinnate Biopharma Statistics Share Statistics Kinnate Biopharma has 47.17M
shares outstanding. The number of shares has increased by 0%
in one year.
Shares Outstanding 47.17M Shares Change (YoY) 0% Shares Change (QoQ) 0% Owned by Institutions (%) n/a Shares Floating 22.68M Failed to Deliver (FTD) Shares 116,752 FTD / Avg. Volume 31.8%
Short Selling Information The latest short interest is 357.94K, so 0% of the outstanding
shares have been sold short.
Short Interest 357.94K Short % of Shares Out n/a Short % of Float n/a Short Ratio (days to cover) 1
Valuation Ratios The PE ratio is -0.98 and the forward
PE ratio is -2.73.
Kinnate Biopharma's PEG ratio is
0.15.
PE Ratio -0.98 Forward PE -2.73 PS Ratio 0 Forward PS n/a PB Ratio 0.69 P/FCF Ratio -1.1 PEG Ratio 0.15
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Kinnate Biopharma.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 13.19,
with a Debt / Equity ratio of 0.02.
Current Ratio 13.19 Quick Ratio 13.19 Debt / Equity 0.02 Debt / EBITDA -0.03 Debt / FCF -0.03 Interest Coverage 0
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee n/a Profits Per Employee $-1.34M Employee Count 84 Asset Turnover 0 Inventory Turnover n/a
Taxes Income Tax n/a Effective Tax Rate 0%
Stock Price Statistics The stock price has increased by 0% in the
last 52 weeks. The beta is 1.34, so Kinnate Biopharma's
price volatility has been higher than the market average.
Beta 1.34 52-Week Price Change n/a 50-Day Moving Average 2.49 200-Day Moving Average 2.27 Relative Strength Index (RSI) 62.67 Average Volume (20 Days) 367,164
Income Statement
Revenue n/a Gross Profit -799K Operating Income -119.01M Net Income -112.65M EBITDA -118.21M EBIT -119.01M Earnings Per Share (EPS) -2.42
Full Income Statement Balance Sheet The company has 57M in cash and 3.17M in
debt, giving a net cash position of 53.82M.
Cash & Cash Equivalents 57M Total Debt 3.17M Net Cash 53.82M Retained Earnings -372.01M Total Assets 173.6M Working Capital 146.18M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -100.04M
and capital expenditures 0, giving a free cash flow of -100.04M.
Operating Cash Flow -100.04M Capital Expenditures n/a Free Cash Flow -100.04M FCF Per Share -2.15
Full Cash Flow Statement Margins
Gross Margin n/a Operating Margin n/a Pretax Margin n/a Profit Margin n/a EBITDA Margin n/a EBIT Margin n/a FCF Margin n/a
